Monitoring tumor response to the vascular disrupting agent CKD-516 in …
페이지 정보
본문
Ahn SY, Goo JM, Lee KH, Ha S, Paeng JC.
- 이전글Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor. 20.05.19
- 다음글Radiofrequency ablation for treatment of locally recurrent thyroid cancer presenting as a metastatic lymph node with dense macrocalcification: A case report and literature review. 20.05.19
댓글목록
등록된 댓글이 없습니다.